A detailed history of High Mark Wealth Management LLC transactions in Neogenomics Inc stock. As of the latest transaction made, High Mark Wealth Management LLC holds 96,800 shares of NEO stock, worth $1.74 Million. This represents 0.79% of its overall portfolio holdings.

Number of Shares
96,800
Previous 92,800 4.31%
Holding current value
$1.74 Million
Previous $1.29 Million 10.88%
% of portfolio
0.79%
Previous 0.78%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$13.4 - $17.73 $53,600 - $70,920
4,000 Added 4.31%
96,800 $1.43 Million
Q2 2024

Jul 29, 2024

BUY
$13.01 - $15.77 $1.17 Million - $1.42 Million
89,800 Added 2993.33%
92,800 $1.29 Million
Q3 2023

Oct 18, 2023

SELL
$12.15 - $17.85 $15,187 - $22,312
-1,250 Reduced 29.41%
3,000 $36,000
Q2 2023

Jul 26, 2023

BUY
$14.1 - $19.83 $17,625 - $24,787
1,250 Added 41.67%
4,250 $68,000
Q1 2023

Apr 20, 2023

SELL
$9.09 - $19.45 $1,818 - $3,890
-200 Reduced 6.25%
3,000 $52,000
Q4 2022

Feb 01, 2023

BUY
$6.45 - $12.07 $3,225 - $6,035
500 Added 18.52%
3,200 $29,000
Q2 2022

Jul 19, 2022

BUY
$7.06 - $13.97 $10,590 - $20,955
1,500 Added 125.0%
2,700 $22,000
Q4 2021

Jan 20, 2022

SELL
$30.49 - $48.49 $54,516 - $86,700
-1,788 Reduced 59.84%
1,200 $41,000
Q3 2021

Nov 01, 2021

BUY
$41.66 - $52.52 $9,206 - $11,606
221 Added 7.99%
2,988 $144,000
Q2 2021

Aug 02, 2021

BUY
$36.62 - $51.69 $87,668 - $123,745
2,394 Added 641.82%
2,767 $125,000
Q1 2021

Apr 22, 2021

BUY
$41.56 - $59.88 $2,368 - $3,413
57 Added 18.04%
373 $18,000
Q4 2020

Jan 27, 2021

SELL
$36.08 - $56.47 $69,742 - $109,156
-1,933 Reduced 85.95%
316 $17,000
Q3 2020

Oct 26, 2020

BUY
$33.26 - $40.48 $66,919 - $81,445
2,012 Added 848.95%
2,249 $83,000
Q2 2020

Jul 22, 2020

BUY
$24.21 - $31.02 $5,737 - $7,351
237 New
237 $7,000

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $2.26B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track High Mark Wealth Management LLC Portfolio

Follow High Mark Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Mark Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Mark Wealth Management LLC with notifications on news.